Israeli Tumor-Freezing Technology Gains Ground in Brazil
IceCure Medical's tumor-freezing ProSense technology is gaining commercial traction in Brazil for breast, lung, kidney, and musculoskeletal tumors.
IceCure Medical Ltd
Israeli Medtech Firm IceCure Gains FDA Approval for Post-Market Breast Cancer Study
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
Israeli MedTech Firm IceCure Gains Swiss Approval for Cryoablation Cancer Therapy
Israeli MedTech Firm IceCure gains Swiss approval for revolutionary cryoablation cancer therapy, expanding global reach with innovative treatment options.
Navigation